Fibrin Fibrinogen Degradation Products
"Fibrin Fibrinogen Degradation Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.
| Descriptor ID |
D005338
|
| MeSH Number(s) |
D12.776.124.270.300 D12.776.811.300.290
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrin Fibrinogen Degradation Products".
Below are MeSH descriptors whose meaning is more specific than "Fibrin Fibrinogen Degradation Products".
This graph shows the total number of publications written about "Fibrin Fibrinogen Degradation Products" by people in this website by year, and whether "Fibrin Fibrinogen Degradation Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 3 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 17 | 21 | 38 |
| 2018 | 16 | 20 | 36 |
| 2019 | 8 | 3 | 11 |
| 2020 | 38 | 161 | 199 |
| 2021 | 28 | 70 | 98 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibrin Fibrinogen Degradation Products" by people in Profiles.
-
Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis. Shock. 2022 01 01; 57(1):1-6.
-
Clinical Implications of Hematologic and Hemostatic Abnormalities in Children With COVID-19. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e282-e286.
-
Biomarkers for Prognosis and Treatment Response in COVID-19 Patients. Ann Lab Med. 2021 Nov 01; 41(6):540-548.
-
Paediatric post-COVID-19 hyperinflammatory syndrome mimicking appendicitis: a case series. Ann R Coll Surg Engl. 2021 Sep; 103(8):604-611.
-
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021 08 31; 42(33):3127-3142.
-
An oral combined contraceptive user with elevated D-dimer post COVID-19: a case report. BMC Womens Health. 2021 08 28; 21(1):320.
-
Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One. 2021; 16(8):e0256226.
-
D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One. 2021; 16(8):e0256744.
-
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke. Stroke. 2021 11; 52(11):e706-e709.
-
The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism. Acad Emerg Med. 2021 10; 28(10):1142-1149.